Bharat Biotech's COVID-19 vaccine Covaxin got permission for phase 3 trial

Story by Rakesh Bind 11 months ago

Drugs Controller General of India (DCGI) on Friday gave Bharat Biotech permission to conduct a Phase-3 clinical trial for the indigenous COVID-19 vaccine - Covaxin. Bharat Biotech has partnered with the Indian Council of Medical Research (ICMR) for a country-made covid-19 vaccine using the virus strain isolated by ICMR's National Institute of Virology (NIV) based in Pune.

Read more at India Today

Stay informed

*Subscribe to our newsletter to receive early discount offers, updates and new products info.


Popular tags

#Ssr #ipl #covid19 #Arnab
Menu Saved